Bialoom Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 2

Bialoom General Information

Description

Developer of silicon plasma-photonic biosensing chips designed for the treatment of severe infections and rapid diagnosis. The company uses proprietary plasmonic interferometric sensors for super-sensitive detection of multiple critical biomarkers and offers features that include plasmonic interferometric sensors, microliter-scale analysis, CMOS-guided manufactured chips, and outcome analysis integrating patient records and demographics, enabling clinicians to analyze acute infections faster, select treatment, and monitor disease progression within minutes.

Contact Information

Website
www.bialoom.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2, Theodorou Kolokotroni Street
  • Engomi
  • Nicosia, 2408
  • Cyprus
+357
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 2, Theodorou Kolokotroni Street
  • Engomi
  • Nicosia, 2408
  • Cyprus
+357

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bialoom Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator 27-May-2021 Completed Generating Revenue
4. Grant 01-Apr-2020 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2020 Completed Generating Revenue
2. Grant 02-Dec-2019 $105K Completed Generating Revenue
1. Early Stage VC 01-Jan-2019 Completed Generating Revenue
To view Bialoom’s complete valuation and funding history, request access »

Bialoom Patents

Bialoom Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4810941-A1 Waveguide for the analysis of biological samples Pending 21-Mar-2025
US-20260287816-A1 Waveguide for the analysis of biological samples Pending 21-Mar-2025
EP-4466530-A1 Optical interferometric sensor Pending 21-Jan-2022
US-20250093346-A1 Optical interferometric sensor Pending 21-Jan-2022
WO-2023139408-A1 Optical interferometric sensor Inactive 21-Jan-2022 G01N33/54373
To view Bialoom’s complete patent history, request access »

Bialoom Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bialoom Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
StartSmart South Eastern Europe Accelerator/Incubator
Gravity Ventures (Cyprus) Accelerator/Incubator Minority
To view Bialoom’s complete investors history, request access »

Bialoom FAQs

  • When was Bialoom founded?

    Bialoom was founded in 2018.

  • Where is Bialoom headquartered?

    Bialoom is headquartered in Nicosia, Cyprus.

  • What is the size of Bialoom?

    Bialoom has 7 total employees.

  • What industry is Bialoom in?

    Bialoom’s primary industry is Diagnostic Equipment.

  • Is Bialoom a private or public company?

    Bialoom is a Private company.

  • What is Bialoom’s current revenue?

    The current revenue for Bialoom is .

  • Who are Bialoom’s investors?

    StartSmart South Eastern Europe and Gravity Ventures (Cyprus) have invested in Bialoom.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process